Literature DB >> 24979485

Horizontal infection control strategy decreases methicillin-resistant Staphylococcus aureus infection and eliminates bacteremia in a surgical ICU without active surveillance.

Maria X Traa1, Lorena Barboza, Shira Doron, David R Snydman, Farzad Noubary, Stanley A Nasraway.   

Abstract

OBJECTIVE: Methicillin-resistant Staphylococcus aureus infection is a significant contributor to morbidity and mortality in hospitalized patients worldwide. Numerous healthcare bodies in Europe and the United States have championed active surveillance per the "search and destroy" model. However, this strategy is associated with significant economic, logistical, and patient costs without any impact on other hospital-acquired pathogens. We evaluated whether horizontal infection control strategies could decrease the prevalence of methicillin-resistant S. aureus infection in the ICU, without the need for active surveillance. DESIGN AND
SETTING: Retrospective, observational study in the surgical ICU of a tertiary care medical center in Boston, MA, from 2005 to 2012. PATIENTS: A total of 6,697 patients in the surgical ICU.
INTERVENTIONS: Evidence-based infection prevention strategies were implemented in an iterative fashion, including 1) hand hygiene program with refresher education campaign, 2) chlorhexidine oral hygiene program, 3) chlorhexidine bathing, 4) catheter-associated bloodstream infection program, and 5) daily goals sheets.
MEASUREMENTS AND MAIN RESULTS: The prevalence of methicillin-resistant S. aureus infection fell from 2.66 to 0.69 per 1,000 patient days from 2005 to 2012, an average decrease of 21% per year. The biggest decline in rate of infection was detected in 2008, which may suggest that the catheter-associated bloodstream infection prevention program was particularly effective. Among 4,478 surgical ICU admissions over the last 5 years, not a single case of methicillin-resistant S. aureus bacteremia was observed.
CONCLUSIONS: Aggressive multifaceted horizontal infection control is an effective strategy for reducing the prevalence of methicillin-resistant S. aureus infection and eliminating methicillin-resistant S. aureus bacteremia in the ICU without the need for active surveillance and decontamination.

Entities:  

Mesh:

Year:  2014        PMID: 24979485     DOI: 10.1097/CCM.0000000000000501

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Modeling Inpatient Glucose Management Programs on Hospital Infection Control Programs: An Infrastructural Model of Excellence.

Authors:  Nestoras Mathioudakis; Peter J Pronovost; Sara E Cosgrove; Daniel Hager; Sherita Hill Golden
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-07

2.  The epidemiology of hospital-acquired urinary tract-related bloodstream infection in veterans.

Authors:  Payal K Patel; M Todd Greene; Mary A M Rogers; David Ratz; Latoya Kuhn; Jennifer Davis; Sanjay Saint
Journal:  Am J Infect Control       Date:  2018-03-13       Impact factor: 2.918

3.  Another success story for horizontal infection control strategies--which one?*.

Authors:  Kyle J Popovich
Journal:  Crit Care Med       Date:  2014-10       Impact factor: 7.598

4.  Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90%.

Authors:  John Adam Reich; Monica E Goodstein; Susan E Callahan; Kathleen M Callahan; Lindsay W Crossley; Shira I Doron; David R Snydman; Stanley A Nasraway
Journal:  Crit Care       Date:  2015-08-14       Impact factor: 9.097

5.  Low incidence of multidrug-resistant bacteria and nosocomial infection due to a preventive multimodal nosocomial infection control: a 10-year single centre prospective cohort study in neurocritical care.

Authors:  Vera Spatenkova; Ondrej Bradac; Daniela Fackova; Zdenka Bohunova; Petr Suchomel
Journal:  BMC Neurol       Date:  2018-03-07       Impact factor: 2.474

6.  Hospital-associated methicillin-resistant Staphylococcus aureus: A cross-sectional analysis of risk factors in South African tertiary public hospitals.

Authors:  Liliwe L Shuping; Lazarus Kuonza; Alfred Musekiwa; Samantha Iyaloo; Olga Perovic
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.